Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Prolonged QTc Interval in Cancer Therapeutic Drug Development: Defining Arrhythmic Risk in Malignancy

Prolonged QTc Interval in Cancer Therapeutic Drug Development: Defining Arrhythmic Risk in... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Progress in Cardiovascular Diseases Unpaywall

Prolonged QTc Interval in Cancer Therapeutic Drug Development: Defining Arrhythmic Risk in Malignancy

Progress in Cardiovascular DiseasesSep 1, 2010

Prolonged QTc Interval in Cancer Therapeutic Drug Development: Defining Arrhythmic Risk in Malignancy

Progress in Cardiovascular DiseasesSep 1, 2010

 
/lp/unpaywall/prolonged-qtc-interval-in-cancer-therapeutic-drug-development-defining-4J0szDCm3p

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Unpaywall
ISSN
0033-0620
DOI
10.1016/j.pcad.2010.05.005
Publisher site
See Article on Publisher Site

Abstract

Journal

Progress in Cardiovascular DiseasesUnpaywall

Published: Sep 1, 2010

There are no references for this article.